High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

October 11, 2016

Primary Completion Date

March 23, 2023

Study Completion Date

March 23, 2023

Conditions
Cancer
Interventions
OTHER

High-flow Oxygen

Optiflow Respiratory Humidifier used to deliver HFOx. Oxygen flow will be maximized (set between 20 and 60 L/min), if tolerated, to minimize dyspnea. FiO2 will be set at 100%.

OTHER

Low-flow Oxygen

Low-flow Oxygen will be delivered by Optiflow in an identical manner to high flow, except provided at 2 L/min using a nasal cannula identical to that used for high-flow devices.

OTHER

High-flow Air

Two level air flow (high and low) will be delivered by Optiflow in an identical manner to oxygen air flows, except that researchers will use pressurized air instead of oxygen. LFOx and LFAir will be provided at 2 L/min using a nasal cannula identical to that used for high-flow devices.

OTHER

Low-flow Air

Two level air flow (high and low) will be delivered by Optiflow in an identical manner to oxygen air flows, except that researchers will use pressurized air instead of oxygen. LFOx and LFAir will be provided at 2 L/min using a nasal cannula identical to that used for high-flow devices.

Trial Locations (1)

77030

The University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02932332 - High-Flow Oxygen for Dyspnea in Hospitalized Cancer Patients | Biotech Hunter | Biotech Hunter